Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways

作者: Gerwyn Morris , George Anderson , Michael Maes

DOI: 10.1007/S12035-016-0170-2

关键词:

摘要: There is evidence that immune-inflammatory and oxidative nitrosative stress (O&NS) pathways play a role in the pathophysiology of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). also these neuroimmune diseases are accompanied by hypothalamic-pituitary-adrenal (HPA) axis hypoactivity as indicated lowered baseline glucocorticoid levels. This paper aims to review bidirectional communications between O&NS HPA ME/CFS, considering two possibilities: (a) Activation secondary hypofunction via attenuated negative feedback mechanisms, or (b) chronic activated causative hypoactivity. Electronic databases, i.e., PUBMED, Scopus, Google Scholar, were used sources for this narrative using keywords CFS, ME, cortisol, ACTH, CRH, axis, receptor, cytokines, immune, immunity, inflammation, O&NS. Findings show activation ME/CFS probably not may underpin ME/CFS. Mechanistic explanations comprise increased levels tumor necrosis factor-α, T regulatory responses with elevated interleukin-10 transforming growth factor-β, nitric oxide, viral/bacterial-mediated mechanisms. most likely consequence cause wide variety illness.

参考文章(168)
K Nas, R Cevik, S Batum, AJ Sarac, S Acar, S Kalkanli, None, Immunologic and psychosocial status in chronic fatigue syndrome. Bratislavské lekárske listy. ,vol. 112, pp. 208- 212 ,(2011)
J.-M. Triffaux, J. Demonty, M. Moutschen, J.-J. Legros, P.J. Lefebvre, Pathogenic Tracks in Fatigue Syndromes Acta Clinica Belgica. ,vol. 49, pp. 274- 289 ,(1994) , 10.1080/17843286.1994.11718404
Valery Grinevich, X‐M Ma, JP Herman, D Jezova, I Akmayev, Greti Aguilera, None, Effect of Repeated Lipopolysaccharide Administration on Tissue Cytokine Expression and Hypothalamic−Pituitary−Adrenal Axis Activity in Rats Journal of Neuroendocrinology. ,vol. 13, pp. 711- 723 ,(2001) , 10.1046/J.1365-2826.2001.00684.X
M. Aringer, E. Feierl, J. Smolen, Zytokinblockade – eine vielversprechende Therapieoption bei SLE Zeitschrift Fur Rheumatologie. ,vol. 67, pp. 315- 317 ,(2008) , 10.1007/S00393-008-0303-8
Adrienne L. Bennett, Chun C. Chao, Shuxian Hu, Dedra Buchwald, Laura R. Fagioli, Peter H. Schur, Phillip K. Peterson, Anthony L. Komaroff, Elevation of bioactive transforming growth factor-β in serum from patients with chronic fatigue syndrome Journal of Clinical Immunology. ,vol. 17, pp. 160- 166 ,(1997) , 10.1023/A:1027330616073
BE Miller, O Deutsch, M Redlich, YT Konttinen, R Benoliel, B Zaks, E Davidovich, A Palmon, DJ Aframian, Sialochemistry and cortisol levels in patients with Sjogren's syndrome. Oral Diseases. ,vol. 18, pp. 255- 259 ,(2012) , 10.1111/J.1601-0825.2011.01866.X
Gary Wand, Mary Ann C. Stephens, Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol research : current reviews. ,vol. 34, pp. 468- 483 ,(2012)
Tsilke Pearlman, Mark H. Wener, Dedra Buchwald, Phalla Kith, Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. The Journal of Rheumatology. ,vol. 24, pp. 372- 376 ,(1997)